NCT03464227

A Study to Test the Safety, Pharmacokinetics, and Pharmacodynamics of Single Ascending Intravenous Doses of UCB0107 in Healthy Male Subjects

A Subject-Blind, Investigator-Blind, Randomized, Placebo-Controlled, First-in-Human Study to Evaluate Safety and Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Intravenous Doses of UCB0107 in Healthy Male Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 52 (actual)
• Sponsor: UCB Biopharma S.P.R.L. · Industry
• Sex: Male
• Age: 18 Years – 75 Years
• Healthy volunteers: Accepted

Summary

The purpose of the study is to evaluate the safety and tolerability of single ascending doses of UCB0107 administered by intravenous (iv) infusion in healthy male subjects.

Conditions

• Healthy Male Volunteers

Interventions

Type	Name	Description
DRUG	UCB0107	* Pharmaceutical form: solution for infusion * Route of administration: intravenous use
OTHER	Placebo	* Pharmaceutical form: intravenous infusion * Route of administration: intravenous use

Timeline

• Start date: 2018-02-16
• Primary completion: 2018-12-01
• Completion: 2018-12-01
• First posted: 2018-03-13
• Last updated: 2018-12-12

Locations

1 site across 1 country: Germany